SEC
SlamSEC
SearchBrowseEarnings

Pluri Inc.

Nasdaq:PLUR
Biological Products, (No Diagnostic Substances)·HAIFA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(922 total)

TypeDateAccessionPeriodSize
8-K
Mar 2, 2026
0001213900-26-022025CURRENT REPORT
Feb 27, 2026
184.9 KB
10-Q
Feb 12, 2026
0001213900-26-015550QUARTERLY REPORT
Dec 31, 2025
4.7 MB
8-K
Jan 22, 2026
0001213900-26-006685CURRENT REPORT
Jan 20, 2026
193.2 KB
4
Jan 5, 2026
0001213900-26-001394
Dec 30, 2025
40.5 KB
SCHEDULE 13D/A
Jan 5, 2026
0001213900-26-001393
—
32.1 KB
SCHEDULE 13D/A
Dec 15, 2025
0001213900-25-121483
—
28.7 KB
8-K
Dec 9, 2025
0001213900-25-119651CURRENT REPORT
Dec 8, 2025
567.2 KB
4
Dec 8, 2025
0001213900-25-119238
Dec 4, 2025
11.0 KB
4
Dec 8, 2025
0001213900-25-119235
Dec 4, 2025
5.2 KB
4
Dec 8, 2025
0001213900-25-119234
Dec 4, 2025
5.9 KB
4
Dec 8, 2025
0001213900-25-119233
Dec 4, 2025
5.2 KB
4
Dec 8, 2025
0001213900-25-119232
Dec 4, 2025
5.2 KB
4
Dec 8, 2025
0001213900-25-119230
Dec 4, 2025
5.3 KB
4
Dec 8, 2025
0001213900-25-119229
Dec 4, 2025
5.9 KB
4
Nov 20, 2025
0001213900-25-112942
Oct 29, 2025
19.2 KB
4
Nov 13, 2025
0001213900-25-109609
Nov 12, 2025
5.5 KB
10-Q
Nov 12, 2025
0001213900-25-109174QUARTERLY REPORT
Sep 30, 2025
3.7 MB
4
Oct 16, 2025
0001213900-25-099642
Oct 15, 2025
7.9 KB
8-K
Oct 16, 2025
0001213900-25-099632CURRENT REPORT
Oct 15, 2025
186.8 KB
SCHEDULE 13G/A
Oct 14, 2025
0001213900-25-098726
—
21.5 KB
EFFECT
Sep 25, 2025
9999999995-25-003101
—
2.1 KB
CORRESP
Sep 23, 2025
0001213900-25-090432
—
6.4 KB
3
Sep 22, 2025
0001213900-25-090190
Sep 10, 2025
3.3 KB
UPLOAD
Sep 22, 2025
0000000000-25-010320
—
39.5 KB
S-3
Sep 17, 2025
0001213900-25-088655REGISTRATION STATEMENT
—
380.7 KB
25 filings shown
CEO
Yanay Yaky
CFO
Zalts Liat